u Established a project establishment system with a clear commercialization concept and stable supply chain as the core, and a project management system with commercial access as the goal.
u Integrated CRO, supply chain platforms, and commercialization resources of drugs and devices to create the MAH model for the full life cycle management of drugs and devices.
u The commercialization team has been engaged in marketing, government access, R&D and production for more than 20 years, and has strong government affairs capabilities.
u Holds and manages 6 drug and device products, and the continuous hematopoietic capacity ensures a strong development momentum.